Metraipolis › archive › dc_b258bebf877f
An antibody-drug conjugate designed through clone and isotype selection restricts the growth of CSPG4-expressing triple-negative breast cancer — Europe PMC PMID:41794948
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41794948
- DOI
- 10.1038/s41698-[numero omesso]-0
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T01:16:05.924Z
- SHA-256 of the archived text
03de23b51e138548191d7c3252997d7a6476e8e510132cd6514876f63f82f735- Stable URL of this page
https://metraipolis.com/documento/dc_b258bebf877f
How to cite
An antibody-drug conjugate designed through clone and isotype selection restricts the growth of CSPG4-expressing triple-negative breast cancer — Europe PMC PMID:41794948 — Europe PMC (en), https://europepmc.org/article/MED/41794948 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b258bebf877f (Metraipolis archive dc_b258bebf877f, sha256 03de23b51e138548191d7c3252997d7a6476e8e510132cd6514876f63f82f735)
BibTeX
@misc{dcb258bebf877f,
title = {An antibody-drug conjugate designed through clone and isotype selection restricts the growth of CSPG4-expressing triple-negative breast cancer — Europe PMC PMID:41794948},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41794948},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b258bebf877f; sha256 03de23b51e138548191d7c3252997d7a6476e8e510132cd6514876f63f82f735},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41794948. Agents can read the archived copy with the MCP tool read_document.